IM 2 autoregulator: controls blue pigment and nucleoside antibiotic production in Streptomyces; RN given for (3R-(3alpha(R*),4beta))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 130246 |
| MeSH ID | M0279733 |
| Synonym |
|---|
| (3r,4r)-3-[(1r)-1-hydroxybutyl]-4-(hydroxymethyl)oxolan-2-one |
| 2-(1'-hydroxybutyl)-3-(hydroxymethyl)butanolide |
| 124753-55-5 |
| im-2 autoregulator |
| im 2 autoregulator |
| 3-(1-hydroxybutyl)-4-methyloxolan-2-one |
| DTXSID70924921 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.22) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||